GlassScriptPhysician profile
Melissa Y Tharpe
NPI 1629102868
$24,381.01
in general payments reported to CMS, 2019-2025
9 companies · $18K in 2025
The $18K reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,193 · 2024: $5,425 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $5,342 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,600 · Food and Beverage: $1,247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,000.00 |
| Travel and Lodging | $5,341.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,600.00 |
| Food and Beverage | $1,246.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $18,900.42 | 2024-2025 | Novasure, None, Acessa Provu System |
| Cytyc Surgical Products, LLC | $2,328.43 | 2025 | Novasure, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $1,700.38 | 2025 | |
| Pfizer INC. | $1,133.37 | 2022-2024 | |
| Abbvie INC. | $119.99 | 2022-2025 | |
| Astellas Pharma US INC | $108.94 | 2024 | Veozah |
| Novo Nordisk INC | $49.93 | 2025 | Wegovy |
| Cumberland Pharmaceuticals, INC. | $24.45 | 2025 | Caldolor |
| Janssen Biotech, INC. | $15.10 | 2025 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Tharpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.